Lovric Svjetlana, Goncalves Sara, Gee Heon Yung, Oskouian Babak, Srinivas Honnappa, Choi Won-Il, Shril Shirlee, Ashraf Shazia, Tan Weizhen, Rao Jia, Airik Merlin, Schapiro David, Braun Daniela A, Sadowski Carolin E, Widmeier Eugen, Jobst-Schwan Tilman, Schmidt Johanna Magdalena, Girik Vladimir, Capitani Guido, Suh Jung H, Lachaussée Noëlle, Arrondel Christelle, Patat Julie, Gribouval Olivier, Furlano Monica, Boyer Olivia, Schmitt Alain, Vuiblet Vincent, Hashmi Seema, Wilcken Rainer, Bernier Francois P, Innes A Micheil, Parboosingh Jillian S, Lamont Ryan E, Midgley Julian P, Wright Nicola, Majewski Jacek, Zenker Martin, Schaefer Franz, Kuss Navina, Greil Johann, Giese Thomas, Schwarz Klaus, Catheline Vilain, Schanze Denny, Franke Ingolf, Sznajer Yves, Truant Anne S, Adams Brigitte, Désir Julie, Biemann Ronald, Pei York, Ars Elisabet, Lloberas Nuria, Madrid Alvaro, Dharnidharka Vikas R, Connolly Anne M, Willing Marcia C, Cooper Megan A, Lifton Richard P, Simons Matias, Riezman Howard, Antignac Corinne, Saba Julie D, Hildebrandt Friedhelm
J Clin Invest. 2017 Mar 1;127(3):912-928. doi: 10.1172/JCI89626. Epub 2017 Feb 6.
Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1Δ yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.
类固醇抵抗性肾病综合征(SRNS)导致15%的慢性肾脏病病例。在症状出现在25岁之前的SRNS患者中,约30%可检测到40多个单基因中的1个发生突变。然而,许多患者的遗传病因仍不清楚。在此,我们进行了全外显子组测序以确定SRNS的隐性病因。在7个患有SRNS且伴有先天性鱼鳞病、肾上腺功能不全、免疫缺陷和神经缺陷的家系中,我们在编码鞘氨醇-1-磷酸(S1P)裂解酶的SGPL1中鉴定出9种不同的隐性突变。所有突变均导致SGPL1蛋白减少或缺失和/或酶活性降低。代表SGPL1突变的cDNA过表达导致SGPL1亚细胞定位错误。此外,野生型人SGPL1的表达挽救了SGPL1缺陷的dpl1Δ酵母菌株的生长,而疾病相关变体的表达则不能。免疫荧光显示SGPL1在小鼠足细胞和系膜细胞中表达。在大鼠系膜细胞中敲低Sgpl1会抑制细胞迁移,S1P受体拮抗剂VPC23109可部分挽救这种抑制作用。在果蝇中,缺乏SGPL1的Sply突变体在肾细胞中表现出类似于肾病综合征的表型。野生型Sply可挽救这种表型,而疾病相关变体则不能。这些结果共同表明,SGPL1突变导致了一种综合征形式的SRNS。